Cost-effective risk reduction and quality maintenance in our clients’ projects. Providing input into development and GTM strategies, facilitating fund-raising, participating in co-development and risk sharing.
We partner with centres of excellence to drive efficient early development, getting our clients to GO/NOGO decisions faster through effective design and conduct of First-In-Human, BA/BE, Biosimilar and other early-phase studies. We have a strong network of pre-clinical services with strategic partners across the globe.
PHASE II & III
Partnering with our customers to bring products to market efficiently and effectively, saving time, reducing costs and improving quality using innovative and adaptive digital technology in clinical trials.
Our capabilities include Strategic & Needs Assessments, Study Protocol Design, Risk-Benefit Risk Management, Patient Reported Outcomes, Literature Reviews & Meta-Analyses, Biostatistics, Monitoring & Evaluation, Medical Writing & Pharmacoeconomic Training.
MARKET ACCESS SOLUTIONS
Guiding our clients in creating effective market access solutions based on Needs Assessment, Pricing & Reimbursement Strategy, Health Economics, Pharmacoeconomics and Value Propositions.
LATE-PHASE & POST-APPROVAL
Partnering with our clients with expert guidance to lead products through late phase research toward increased market access. Studies are innovative and practical and include Phase IV trials, Observational Studies, Registries & Retrospective Studies.
An Electronic Data Capture (EDC) platform built for the emerging market, making use of first world technologies. The Web-based platform can be access from any device.
An Web-based platform built on the foundation of our validated EDC platform (“Nukleus”) to collect and manage adverse drug reactions between research sites and safety physicians.
Our web-based EDC was developed for the emerging market – taking instability of infrastructure in rural areas into account.
Read the latest Clinical Research and Outcomes Research
articles in our News Stand.
Apple launched a large-scale heart rate study in collaboration with Stanford Medicine in November 2017. The study (called Apple Heart Study) was conducted to improve technology that identifies irregular heart rhythms. Early diagnosis and treatment can prevent life-threatening heart complications, including strokes. The study was carried out in the form of an app, open to […]
It’s an exciting time as the industry takes hold of clinical trial technology. eSource, by extending eClinical functionality to the site level, is a key component of the future of clinical research and equips organizations with efficiencies that brings about higher trial volume and lower margins. This technology has led to unparalleled efficiencies in data […]
Presented by Dr Tienie Stander Elsebe Klinck Ruwaida Sheik Ntuthuko Bhengu Christoff Raath Dr. Rajesh Patel To understand what may come, we need to have a deeper upstanding of healthcares complexities. Join TCD as we unfold healthcare reform in South Africa. Journey with us as we unpack healthcare post 1994 to current! In bridging the […]